You have 9 free searches left this month | for more free features.

Polycythemia Vera

Showing 1 - 25 of 416

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Polycythemia Vera Trial (Open-label rusfertide)

Not yet recruiting
  • Polycythemia Vera
  • Open-label rusfertide
  • (no location specified)
Sep 5, 2023

Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

Recruiting
  • Polycythemia Vera
    • Sohag, Egypt
      Faculty of Medicine
    Aug 12, 2023

    Polycythemia Vera Trial (Hydroxyurea)

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    May 2, 2023

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Polycythemia Vera Trial (bomedemstat)

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    Oct 24, 2022

    Real World Evidence of Fedratinib Effectiveness in MF

    Not yet recruiting
    • Primary Myelofibrosis
    • +2 more
    • (no location specified)
    May 22, 2023

    Identify and Describe Predictive Factors for Thromboembolic

    Not yet recruiting
    • Polycythemia Vera
    • Hydroxyurea
    • Ruxolitinib
    • (no location specified)
    Nov 2, 2022

    Polycythemia Vera Trial in Hirakata, Izumo, Osaka (PPMX-T003)

    Recruiting
    • Polycythemia Vera
    • Hirakata, Osaka, Japan
    • +2 more
    Nov 14, 2022

    QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    Sep 30, 2022

    Assess the Safety of Fedratinib in Korean Myelofibrosis

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Polycythemia Vera Trial (SLN124, Placebo)

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    Aug 10, 2022

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

      Not yet recruiting
      • Polycythemia Vera
      • Ropeginterferon alfa-2b-njft (P1101)
      • (no location specified)
      Jul 28, 2022

      Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

      Not yet recruiting
      • Polycythemia Vera (PV)
      • Mie, Japan
      • +5 more
      Aug 15, 2023

      Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

      Recruiting
      • Myelofibrosis Due to and Following Polycythemia Vera
      • Basking Ridge, New Jersey
      • +6 more
      Jan 26, 2023

      Ruxolitinib for Polycythemia Vera in Patients Resistant to or

      Completed
      • Polycythemia Vera (PV)
      • Ruxolitinib
      • East Hanover, New Jersey
        Novartis Investigative Site
      Jun 29, 2022

      Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)

      Recruiting
      • Phlebotomy Dependent Polycythemia Vera
      • Orange, California
      • +4 more
      Aug 1, 2022

      Polycythemia Vera Trial in Italy

      Recruiting
      • Polycythemia Vera
        • Reggio Calabria, Calabria, Italy
        • +21 more
        Nov 10, 2023

        Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

        Active, not recruiting
        • Myelofibrosis
        • Polycythemia Vera
        • Phoenix, Arizona
        • +4 more
        Jun 20, 2022

        Polycythemia Vera Trial (Ruxolitinib)

        Available
        • Polycythemia Vera
        • (no location specified)
        Mar 7, 2022

        Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

        Completed
        • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
        • +2 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        May 27, 2022

        Polycythemia Vera, Essential Thrombocythemia, and

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Next-generation sequencing
        • (no location specified)
        Jun 27, 2022

        Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Jan 6, 2023